Application-level market taxonomy reveals four demand silos: dietary supplements, functional food & beverage, personal care, and pharmaceuticals. Dietary supplements dominate, absorbing 51 % of 2023 global sales; capsules and tablets offer convenient dosing and allow health-claim positioning, so brands willingly pay 15–25 % ingredient mark-ups. Functional food & beverage accounts for 26 %, where heat-stable extract powders are incorporated in RTD coffees, dairy alternatives, and nutrition bars targeting lifestyle positioning rather than therapeutic claims. Personal care contributes 14 %, primarily East-Asian anti-ageing masks and serums that leverage reishi’s beta-glucan content for hydration and antioxidant stories. Pharmaceuticals, though only 9 % by volume, are the fastest-growing segment as developers investigate triterpenes for adjuvant oncology protocols; regulatory-grade APIs command double the price of food-grade powders, amplifying revenue impact despite modest tonnage.